Serveur d'exploration Covid (26 mars) - Curation (Istex)

Index « AbsEn.i » - entrée « application »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
applicable < application < applications  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000036 (1968) V. M. Adamovi [Yougoslavie]Eine Methode zur halbquantitativen Bestimmung kleiner Mengen von Organochlorpestiziden mittels aromatischer Amine mit Hilfe der Ringofenmethode
000038 (2006) Sanghoon Moon [Corée du Sud, Niger] ; Yanga Byun [Corée du Sud, Niger] ; Kyungsook Han [Corée du Sud]Prediction of Ribosomal -1 Frameshifts in the Escherichia coli K12 Genome
000111 (2010) Rejish Kumar V. J [Corée du Sud] ; Byeong Joo Seo [Corée du Sud] ; Mi Ran Mun [Corée du Sud] ; Chul-Joong Kim [Corée du Sud] ; Insun Lee [Corée du Sud] ; Hongik Kim [Corée du Sud] ; Yong-Ha Park [Corée du Sud]Putative probiotic Lactobacillus spp. from porcine gastrointestinal tract inhibit transmissible gastroenteritis coronavirus and enteric bacterial pathogens
000124 (2005) Yinglei Song [États-Unis] ; Chunmei Liu [États-Unis] ; Xiuzhen Huang [États-Unis] ; Russell L. Malmberg [États-Unis] ; Ying Xu [États-Unis] ; Liming Cai [États-Unis]Efficient Parameterized Algorithm for Biopolymer Structure-Sequence Alignment
000129 (2007) William E. Severson [États-Unis] ; Nice Shindo ; Mindy Sosa [États-Unis] ; Thomas Fletcher [États-Unis] ; E. Lucile White [États-Unis] ; Subramaniam Ananthan [États-Unis] ; Colleen B. Jonsson [États-Unis]Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application in Screening of a 100,000-Compound Library
000359 (2004) Vladimir Evilevitch [Suède] ; Kristina Norrgren [Suède] ; Lennart Greiff [Suède] ; Per Wollmer [Suède]Microvascular response in guinea pig skin to histamine challenge with and without application of skin window
000373 (2004) A. Gerson Greenburg [États-Unis] ; Hae Won Kim [États-Unis]Civilian Uses of Hemoglobin‐based Oxygen Carriers
000393 (2008) Bernard Horowitz [États-Unis] ; Michael Busch [États-Unis]Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin
000394 (2006) Yasuko Tsunetsugu-Yokota [Japon] ; Kazuo Ohnishi [Japon] ; Toshitada Takemori [Japon]Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine
000420 (2012) Bruno St-Aubin [Canada] ; Mir Abolfazl Mostafavi [Canada] ; Stéphane RocheDevelopment of a collaborative geospatial augmented reality system in support of urban design practice
000430 (1987) R. Rott [Allemagne] ; H.-D. Klenk [Allemagne]Significance of viral glycoproteins for infectivity and pathogenicity
000553 (2004) Nilesh P. Teli [États-Unis] ; Michael P. Timko [États-Unis]Recent developments in the use of transgenic plants for the production of human therapeutics and biopharmaceuticals
000684 (2012) Francesca Sidoti [Italie] ; Massimiliano Bergallo [Italie] ; Cristina Costa [Italie] ; Rossana Cavallo [Italie]Alternative Molecular Tests for Virological Diagnosis
000715 (2013) Catherine A. Goubko [Canada] ; Ajoy Basak [Canada] ; Swapan Majumdar [Canada] ; Harold Jarrell [Canada] ; Nam Huan Khieu [Canada] ; Xudong Cao [Canada]Comparative analysis of photocaged RGDS peptides for cell patterning
000725 (2012) M. Motavaf [Iran] ; S. Safari [Iran] ; S. M. Alavian [Iran]Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C
000740 (2010) S. Chey [Allemagne] ; C. Claus [Allemagne] ; U. G. Liebert [Allemagne]Validation and application of normalization factors for gene expression studies in rubella virus‐infected cell lines with quantitative real‐time PCR
000815 (2011) Priya S. Shah [États-Unis] ; David V. Schaffer [États-Unis]Antiviral RNAi: Translating Science Towards Therapeutic Success
000827 (2013) Iwona E. Głowacka [Pologne] ; Jan Balzarini [Belgique] ; Andrzej E. Wr Blewski [Pologne]Synthesis and Biological Evaluation of Novel 1,2,3‐Triazolonucleotides

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "application" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "application" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    application
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021